Literature DB >> 22166396

Apathy and depression in Parkinson's disease: the Belgrade PD study report.

Lj Ziropadja1, E Stefanova, M Petrovic, T Stojkovic, V S Kostic.   

Abstract

Apathy and depression are among the most common psychiatric and behavioral disorders associated with Parkinson's disease (PD). The objective of this study was to examine the prevalence and demographic and clinical correlates of apathy and depression in a clinical population-based sample of patients with PD and to assess whether apathy may present as a primary behavioral disturbance independent from depression and cognitive impairment. A series of 360 PD patients underwent psychiatric investigation with the Starkstein's Apathy Scale (AS), and the 17-item Hamilton Depression Rating Scale (HDRS-17), motor scoring with Hoehn and Yahr (HY) staging, and the Unified Parkinson's Disease Rating Scale (UPDRS); and cognitive screening with the Mini-Mental State Examination (MMSE) on the same day. Apathy coexisted with depression in 133 (36.9%) of PD patients, compared with depression without apathy in 16 (4.4%), apathy without depression in 84 (23%), and neither apathy nor depression in 127 PD patients (35.2%). Apathy was associated with higher axial UPDRS impairment score, lower MMSE score, higher l-dopa dosage, and earlier HY stages, while depression was predicted by the more advanced HY stages and younger age of PD patients. These findings suggest that apathy and depression may be separable in PD, although both are common in patients with PD. Therefore these two conditions should be systematically screened and considered in the care and management of PD.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22166396     DOI: 10.1016/j.parkreldis.2011.11.020

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  14 in total

1.  Neuropsychiatric characteristics of GBA-associated Parkinson disease.

Authors:  Matthew Swan; Nancy Doan; Robert A Ortega; Matthew Barrett; William Nichols; Laurie Ozelius; Jeannie Soto-Valencia; Sarah Boschung; Andres Deik; Harini Sarva; Jose Cabassa; Brooke Johannes; Deborah Raymond; Karen Marder; Nir Giladi; Joan Miravite; William Severt; Rivka Sachdev; Vicki Shanker; Susan Bressman; Rachel Saunders-Pullman
Journal:  J Neurol Sci       Date:  2016-08-30       Impact factor: 3.181

2.  New Pharmacological Approaches to Treating Non-Motor Symptoms of Parkinson's Disease.

Authors:  Michael A Kelberman; Elena M Vazey
Journal:  Curr Pharmacol Rep       Date:  2016-09-28

Review 3.  Depression in Patients with Parkinson's Disease: Current Understanding of its Neurobiology and Implications for Treatment.

Authors:  Stéphane Prange; Hélène Klinger; Chloé Laurencin; Teodor Danaila; Stéphane Thobois
Journal:  Drugs Aging       Date:  2022-06-16       Impact factor: 4.271

4.  Serum uric acid is associated with apathy in early, drug-naïve Parkinson's disease.

Authors:  Marina Picillo; Gabriella Santangelo; Marcello Moccia; Roberto Erro; Marianna Amboni; Elio Prestipino; Katia Longo; Carmine Vitale; Emanuele Spina; Giuseppe Orefice; Paolo Barone; Maria Teresa Pellecchia
Journal:  J Neural Transm (Vienna)       Date:  2016-01-06       Impact factor: 3.575

5.  Apathy in untreated, de novo patients with Parkinson's disease: validation study of Apathy Evaluation Scale.

Authors:  Gabriella Santangelo; Paolo Barone; Sofia Cuoco; Simona Raimo; Domenica Pezzella; Marina Picillo; Roberto Erro; Marcello Moccia; Maria Teresa Pellecchia; Marianna Amboni; Franco Santangelo; Santangelo Franco; Dario Grossi; Luigi Trojano; Carmine Vitale
Journal:  J Neurol       Date:  2014-09-17       Impact factor: 4.849

6.  Factor Analysis of the Apathy Scale in Parkinson's Disease.

Authors:  Francesca V Lopez; Graham M L Eglit; Dawn M Schiehser; Eva Pirogovsky-Turk; Irene Litvan; Stephanie Lessig; J Vincent Filoteo
Journal:  Mov Disord Clin Pract       Date:  2019-04-30

Review 7.  Cognitive, Emotional, and Auto-Activation Dimensions of Apathy in Parkinson's Disease.

Authors:  Jonathan Del-Monte; Sophie Bayard; Pierluigi Graziani; Marie C Gély-Nargeot
Journal:  Front Behav Neurosci       Date:  2017-11-21       Impact factor: 3.558

8.  Co-occurrence of apathy and impulse control disorders in Parkinson disease.

Authors:  Bonnie M Scott; Robert S Eisinger; Matthew R Burns; Janine Lopes; Michael S Okun; Aysegul Gunduz; Dawn Bowers
Journal:  Neurology       Date:  2020-10-01       Impact factor: 9.910

9.  Assessment of cognitive impairment in patients with Parkinson's disease: prevalence and risk factors.

Authors:  Qiumei Wang; Zhenxin Zhang; Ling Li; Hongbo Wen; Qun Xu
Journal:  Clin Interv Aging       Date:  2014-02-12       Impact factor: 4.458

10.  Relationships among Depression, Anxiety, Sleep, and Quality of Life in Patients with Parkinson's Disease in Taiwan.

Authors:  Jun-Yu Fan; Bao-Luen Chang; Yih-Ru Wu
Journal:  Parkinsons Dis       Date:  2016-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.